IP Library Granted Patent US 6,946,291
Granted Patent B2
US 6,946,291 · App. 10/813,852 · Granted Sep 20, 2005

Mixed cell diagnostic systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,946,291
App. No.
10/813,852
Granted
Sep 20, 2005
Kind
B2
Abstract

The present invention generally relates to the field of diagnostic microbiology, and, more particularly, to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents.

Claims (52)

1. A composition comprising a mixed cell culture comprising MDCK cells and one or more of A549 cells and H292 cells.

2. The composition of claim 1 , wherein said mixed cell culture comprises MDCK cells and A549 cells.

3. The composition of claim 1 , wherein said mixed cell culture comprises MDCK cells and H292 cells.

4. The composition of claim 1 , wherein said mixed cell culture comprises MDCK cells, A549 cells, and H292 cells.

5. A method for detecting influenza virus, comprising:

1) providing:

a) mixed cell culture comprising MDCK cells and one or more of A549 cells and H292 cells; and

b) a sample;

2) inoculating said mixed cell culture with said sample to produce an inoculated culture; and

3) detecting the presence of influenza virus in said inoculated culture.

6. The method of claim 5 , wherein said influenza virus comprises influenza A virus.

7. The method of claim 5 , wherein said influenza virus comprises influenza B virus.

8. The method of claim 5 , wherein said influenza virus comprises influenza A virus and influenza B virus.

9. The method of claim 5 , wherein said mixed cell culture comprises MDCK cells and A549 cells.

10. The method of claim 9 , wherein said method further comprises detecting the presence of one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

11. The method of claim 5 , wherein said mixed cell culture comprises MDCK cells and H292 cells.

12. The method of claim 11 , wherein said method further comprises detecting the presence of one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

13. The method of claim 5 , wherein said mixed cell culture comprises MDCK cells, A549 cells, and H292cells.

14. The method of claim 13 , wherein said method further comprises detecting the presence of one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

15. A method for producing influenza virus, comprising

1) providing:

a) mixed cell culture comprising MDCK cells and one or more of A549 cells and H292 cells; and

b) a sample; and

2) inoculating said mixed cell culture with said sample to produce an inoculated culture, wherein said inoculated culture produces influenza virus.

16. The method of claim 15 , wherein said influenza virus comprises influenza A virus.

17. The method of claim 15 , wherein said influenza virus comprises influenza B virus.

18. The method of claim 15 , wherein said influenza virus comprises influenza A virus and influenza B virus.

19. The method of claim 15 , wherein said mixed cell culture comprises MDCK cells and A549 cells.

20. The method of claim 19 , wherein said method further comprises producing one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

21. The method of claim 15 , wherein said mixed cell culture comprises MDCK cells and H292 cells.

22. The method of claim 21 , wherein said method further comprises producing one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

23. The method of claim 15 , wherein said mixed cell culture comprises MDCK cells, A549 cells, and H292 cells.

24. The method of claim 23 , wherein said method further comprises producing one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus, and metapneumovirus.

25. A method for detecting metapneumovirus, comprising:

1) providing

a) a mixed cell culture comprising MDCK cells and A549 cells; and

b) a sample;

2) inoculating said mixed cell culture with said sample to produce an inoculated culture; and

3) detecting the presence of metapneumovirus in said inoculated culture.

26. The method of claim 25 , wherein said method further comprises detecting influenza virus.

27. The method of claim 26 , wherein said influenza virus comprises influenza B virus.

28. The method of claim 26 , wherein said influenza virus comprises influenza A virus.

29. The method of claim 26 , wherein said influenza virus comprises influenza A virus and influenza B virus.

30. The method of claim 25 , wherein said method further comprises detecting the presence of one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, and parainfluenza 3 virus.

31. The method of claim 25 , wherein said mixed cell culture further comprises H292 cells.

32. The method of claim 31 , wherein said method further comprises detecting the presence of one or more of respiratory syncytial virus (RSV), adenovirus, parainfluenza 1 virus, parainfluenza 2 virus, and parainfluenza 3 virus.

33. A method for producing metapneumovirus, comprising:

1) providing

a) a mixed cell culture comprising MDCK cells and A549 cells; and

b) a sample;

2) inoculating said cultured cells with said sample to produce an inoculated culture, wherein said inoculated culture produces metapneumovirus.

34. The method of claim 33 , wherein said mixed cell culture further comprises H292 cells.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
CHANGE OF NAME Recorded Mar 21, 2017
From: UNIVERSITY HOSPITALS OF CLEVELAND
To: UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
Reel/Frame 042742/0793 →
CHANGE OF ADDRESS Recorded Jan 12, 2017
From: DIAGNOSTIC HYBRIDS, INC.
To: DIAGNOSTIC HYBRIDS, INC.
Reel/Frame 041351/0846 →
NOTICE OF RELEASE OF GRANT OF PATENT SECURITY INTEREST Recorded Dec 1, 2016
From: BANK OF AMERICA, N.A., AS AGENT
To: DIAGNOSTIC HYBRIDGS, INC.
Reel/Frame 040788/0200 →
GRANT OF PATENT SECURITY INTEREST Recorded Feb 22, 2010
From: DIAGNOSTIC HYBRIDS, INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 023963/0897 →